Pancreatic Cancer Research

ResearcherUniversity of MichiganActive in the last 2 years

Sarah P. Thayer

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0002-4719-5197; OpenAlex author ID A5056158754; NIH RePORTER profile ID 7847360. Sources: OpenAlex.

Their work

Papers
26 (first author 1, last author 3)
Trials
0
Grants
3
Labs led
2
Collaborators
172
Papers, trials and grants by year

2011: 3 papers · 2012: 5 papers · 2013: 4 papers · 2014: 2 papers · 2015: 3 papers · 2016: 1 paper · 2017: 3 papers, 1 grant · 2018: none · 2019: 2 papers · 2020: 2 papers · 2021: 1 paper · 2022: 1 grant · 2023: none · 2024: none · 2025: 1 grant

Papers 26

  1. Management of Locally Advanced Pancreatic Cancer: Results of an International Survey of Current Practice. Co-author DOI 10.1097/sla.0000000000003568↗
  2. Hedgehog signaling promotes angiogenesis directly and indirectly in pancreatic cancer. Co-author DOI 10.1007/s10456-020-09725-x↗
  3. Primary and Metastatic Pancreatic Cancer Cells Exhibit Differential Migratory Potentials. Co-author DOI 10.1097/mpa.0000000000001459↗
  4. Integration of Genomic and Transcriptional Features in Pancreatic Cancer Reveals Increased Cell Cycle Progression in Metastases. Co-author DOI 10.1016/j.ccell.2018.12.010↗
  5. Pancreatic Adenocarcinoma, Version 1.2019. Co-author DOI 10.6004/jnccn.2019.0014↗
  6. Association of Distinct Mutational Signatures With Correlates of Increased Immune Activity in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1001/jamaoncol.2016.3916↗
  7. Tumor engraftment in patient-derived xenografts of pancreatic ductal adenocarcinoma is associated with adverse clinicopathological features and poor survival. Co-author DOI 10.1371/journal.pone.0182855↗
  8. Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. Co-author DOI 10.6004/jnccn.2017.0131↗
  9. Regulation of GLI Underlies a Role for BET Bromodomains in Pancreatic Cancer Growth and the Tumor Microenvironment. Co-author DOI 10.1158/1078-0432.ccr-15-2068↗
  10. Circulating tumor cells found in patients with localized and advanced pancreatic cancer. Last author DOI 10.1097/mpa.0000000000000324↗
  11. Early detection of sporadic pancreatic cancer: summative review. Co-author DOI 10.1097/mpa.0000000000000368↗
  12. Management of the Primary Tumor and Limited Metastases in Patients With Metastatic Pancreatic Cancer. Co-author DOI 10.6004/jnccn.2015.0079↗
  13. Enhanced primary tumor delineation in pancreatic adenocarcinoma using ultrasmall super paramagnetic iron oxide nanoparticle-ferumoxytol: an initial experience … Co-author DOI 10.2147/ijn.s59788↗
  14. Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelines. Co-author DOI 10.6004/jnccn.2014.0106↗
  15. Updated long-term outcomes and prognostic factors for patients with unresectable locally advanced pancreatic cancer treated with intraoperative radiotherapy at… Co-author DOI 10.1002/cncr.28329↗
  16. N0/N1, PNL, or LNR? The effect of lymph node number on accurate survival prediction in pancreatic ductal adenocarcinoma. Last author DOI 10.1007/s11605-012-1974-7↗
  17. Accurate prediction of nodal status in preoperative patients with pancreatic ductal adenocarcinoma using next-gen nanoparticle. First author DOI 10.1593/tlo.13400↗
  18. FOLFIRINOX in locally advanced pancreatic cancer: the Massachusetts General Hospital Cancer Center experience. Co-author DOI 10.1634/theoncologist.2012-0435↗
  19. Intraductal papillary mucinous neoplasms: does a family history of pancreatic cancer matter? Co-author DOI 10.1016/j.pan.2012.05.011↗
  20. Pancreatic ductal adenocarcinoma: long-term survival does not equal cure. Co-author DOI 10.1016/j.surg.2012.05.020↗
  21. Sonic Hedgehog in pancreatic cancer: from bench to bedside, then back to the bench. Last author DOI 10.1016/j.surg.2012.05.030↗
  22. Targeting the MAGE A3 antigen in pancreatic cancer. Co-author DOI 10.1016/j.surg.2012.05.031↗
  23. Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines. Co-author DOI 10.6004/jnccn.2012.0073↗
  24. Neutrophil granulocyte derived MMP-9 is a VEGF independent functional component of the angiogenic switch in pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s10456-011-9207-3↗
  25. Plectin-1 as a novel biomarker for pancreatic cancer. Co-author DOI 10.1158/1078-0432.ccr-10-0999↗
  26. PTEN is a major tumor suppressor in pancreatic ductal adenocarcinoma and regulates an NF-κB-cytokine network. Co-author DOI 10.1158/2159-8290.cd-11-0031↗

Grants 3

  1. Core C-Computational Core P01CA117969↗
  2. Project 1: The Role and Mechanism(s) of MUC16 and MUC16-Cter in Potentiating PC Metastasis P01CA217798↗
  3. PDG Links Stem Cell Niche to Pancreatic Epithelial Renewal, Repair and Cancer R01CA169086↗

Closest collaborators

The 25 strongest of 172 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Andrew Louis Warshaw · 12 shared papers, 2011–2020 · strength 0.59
  2. Michael Anthony Hollingsworth · 3 shared papers, 1 shared grant, 2015–2022 · strength 0.54
  3. Ralph Weissleder · 1 shared paper, 1 shared grant, 2013–2025 · strength 0.49
  4. Anirban Maitra · 1 shared paper, 1 shared grant, 2015–2025 · strength 0.48
  5. Gerald C Chu · 1 shared paper, 1 shared grant, 2011–2025 · strength 0.46
  6. Ronald Anthony Depinho · 1 shared paper, 1 shared grant, 2011–2025 · strength 0.46
  7. Cyril Henri Benes · 1 shared grant, 2025 · strength 0.45
  8. Phillip Andrew Futreal · 1 shared grant, 2025 · strength 0.45
  9. NABEEL El-BARDEESY · 1 shared grant, 2025 · strength 0.45
  10. Lewis C. Cantley · 1 shared grant, 2025 · strength 0.45
  11. Raghu Kalluri · 1 shared grant, 2025 · strength 0.45
  12. James wesley Horner · 1 shared grant, 2025 · strength 0.45
  13. Huamin Wang · 1 shared grant, 2025 · strength 0.45
  14. Tyler Jacks · 1 shared grant, 2025 · strength 0.45
  15. Surinder K. Batra · 1 shared paper, 1 shared grant, 2015–2022 · strength 0.44
  16. Andrew Scott Liss · 6 shared papers, 2012–2020 · strength 0.41
  17. Pankaj Kumar Singh · 1 shared grant, 2022 · strength 0.40
  18. Maneesh Jain · 1 shared grant, 2022 · strength 0.40
  19. Keith D. Lillemoe · 8 shared papers, 2012–2020 · strength 0.38
  20. Mari A. Mino-Kenudson · 8 shared papers, 2011–2017 · strength 0.33
  21. Carlos F. Fernandez-del Castillo · 8 shared papers, 2012–2017 · strength 0.33
  22. Cristina Rosa Ferrone · 8 shared papers, 2012–2019 · strength 0.29
  23. Robert A. Wolff · 5 shared papers, 2012–2019 · strength 0.23
  24. Dirk Bausch · 4 shared papers, 2011–2020 · strength 0.20
  25. Carlos Fernández-del Castillo · 3 shared papers, 2013–2020 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.